{"id":3714,"date":"2026-10-09T14:21:35","date_gmt":"2026-10-09T14:21:35","guid":{"rendered":"https:\/\/nhdbio.com\/?p=3714"},"modified":"2026-10-11T08:32:59","modified_gmt":"2026-10-11T08:32:59","slug":"ll37-essai-sur-lulcere-veineux-resultat-global-versus-sous-groupe","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/fr\/ll37-venous-ulcer-trial-overall-versus-subgroup\/","title":{"rendered":"LL-37 Essai sur les plaies : pourquoi les r\u00e9sultats globaux et par sous-groupes diff\u00e9raient-ils ?"},"content":{"rendered":"

Why study difficult wounds?<\/h2>\n

Some leg ulcers persist despite standard care. The study examined whether a defined topical LL-37 preparation added to compression treatment improved healing. Compression treatment was part of the comparison, so this was not a test of a peptide acting alone without usual care. [1]<\/p>\n

How were the 148 patients compared?<\/h2>\n

Patients were randomized to two LL-37 study concentrations or placebo. The clinical preparation, wound type and accompanying care define the experiment. Randomization supports a comparison; it does not make the patients interchangeable with people who have another kind of wound. [1]<\/p>\n

\n
    \n
  1. 01<\/b>All 148 patients<\/span><\/li>\n
  2. 02<\/b>Overall: no significant improvement<\/span><\/li>\n
  3. 03<\/b>Large-wound subgroup: follow-up question<\/span><\/li>\n<\/ol>
    Reading guide: separates the study questions; not raw data or a prediction of product performance.<\/figcaption><\/figure>\n

    What was the overall result?<\/h2>\n

    In the full study population, the analysis did not identify a statistically significant improvement in healing compared with placebo. This is the starting point of a fair summary. It should remain visible even when another part of the paper sounds encouraging. [1]<\/p>\n

    Where did the positive signal appear?<\/h2>\n

    A post hoc analysis found improvement in several healing measures among patients with larger wounds, defined as at least 10 cm\u00b2. \u201cPost hoc\u201d means the analysis was made after the initial study plan rather than being the main planned test. This suggests a more focused question for another trial. [1]<\/p>\n

    Why not keep only the subgroup result?<\/h2>\n

    The subgroup contains fewer people, and selecting groups after seeing data can produce chance findings. A useful analogy is a class whose average score stays similar while one small group improves: the improvement may deserve attention, but it does not describe the whole class. A new trial would need to test the large-wound question directly.<\/p>\n

    How should the product link be used?<\/h2>\n

    LL-37\u2019s product page helps identify the catalog material for laboratory work. It cannot establish that the material is the clinical topical formulation used in the trial. Describe the experiment and the records needed when asking about supply. For wound research, identity and preparation need to be checked along with the publication.<\/p>\n

    \n

    Related research products<\/h2>\n
    \n
    \n

    LL-37<\/h3>\n

    Research material related to antimicrobial and repair biology.<\/p>\n

    View product and variants \u2192<\/a><\/article>\n<\/div>\n

    For a material inquiry, specify the name, quantity, laboratory purpose and records needed. The team will confirm the available scope.<\/p>\n

    Discuss material requirements \u2192<\/a><\/section>\n

    \n

    Original research and reading notes<\/h2>\n
      \n
    1. LL-37 venous-ulcer trial \u00b7 2021<\/a><\/li>\n<\/ol>\n

      Study amounts and preparations identify experimental conditions, not recommended use. AI-assisted research explanation; sources checked 11 October 2026. NHD catalog materials are for research, development and manufacturing, not human or veterinary use.<\/p>\n<\/section>\n","protected":false},"excerpt":{"rendered":"

      Apprenez \u00e0 lire un essai sur 148 personnes sans s\u00e9lectionner uniquement son r\u00e9sultat le plus favorable.<\/p>","protected":false},"author":1,"featured_media":3927,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"348","pim_article_type":"Published study explanation","pim_evidence_level":"Primary research with study-specific limitations","pim_reviewer":"AI-assisted source and editorial check","pim_reviewed_date":"2026-10-11","pim_editorial_note":"AI-assisted source and readability checks, not independent peer review.","pim_review_status":"reviewed","pim_review_reason":"Study design, numbers, limitations, plain language and relevant product links checked.","pim_creation_method":"AI-assisted writing","pim_sources":"[]","footnotes":""},"categories":[19],"tags":[],"class_list":["post-3714","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-published-study-cases"],"yoast_head":"\nLL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ? | NHD<\/title>\n<meta name=\"description\" content=\"Learn how to read a 148-person trial without selecting only its most positive finding.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/fr\/ll37-essai-sur-lulcere-veineux-resultat-global-versus-sous-groupe\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ?\" \/>\n<meta property=\"og:description\" content=\"Learn how to read a 148-person trial without selecting only its most positive finding.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/fr\/ll37-essai-sur-lulcere-veineux-resultat-global-versus-sous-groupe\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-09T14:21:35+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-11T08:32:59+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3714.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ?\",\"datePublished\":\"2026-10-09T14:21:35+00:00\",\"dateModified\":\"2026-10-11T08:32:59+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/\"},\"wordCount\":426,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3714.jpg\",\"articleSection\":[\"Published Study Reviews\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/\",\"name\":\"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ? | NHD\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3714.jpg\",\"datePublished\":\"2026-10-09T14:21:35+00:00\",\"dateModified\":\"2026-10-11T08:32:59+00:00\",\"description\":\"Learn how to read a 148-person trial without selecting only its most positive finding.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3714.jpg\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/nhd-comic-3714.jpg\",\"width\":1536,\"height\":1024,\"caption\":\"Editorial comic illustration: LL-37 Wound Research. Conceptual cover, not experimental imagery.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll37-venous-ulcer-trial-overall-versus-subgroup\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/fr\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"LL-37 Essai sur les plaies : pourquoi les r\u00e9sultats globaux et de sous-groupes ont-ils diff\u00e9r\u00e9 ? | NHD","description":"Apprenez \u00e0 lire un essai sur 148 personnes sans s\u00e9lectionner uniquement son r\u00e9sultat le plus favorable.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/fr\/ll37-essai-sur-lulcere-veineux-resultat-global-versus-sous-groupe\/","og_locale":"fr_FR","og_type":"article","og_title":"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ?","og_description":"Learn how to read a 148-person trial without selecting only its most positive finding.","og_url":"https:\/\/nhdbio.com\/fr\/ll37-essai-sur-lulcere-veineux-resultat-global-versus-sous-groupe\/","og_site_name":"NHD","article_published_time":"2026-10-09T14:21:35+00:00","article_modified_time":"2026-10-11T08:32:59+00:00","og_image":[{"width":1536,"height":1024,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3714.jpg","type":"image\/jpeg"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"\u00c9crit par":"NHD Technical Team","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ?","datePublished":"2026-10-09T14:21:35+00:00","dateModified":"2026-10-11T08:32:59+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/"},"wordCount":426,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3714.jpg","articleSection":["Published Study Reviews"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/","url":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/","name":"LL-37 Essai sur les plaies : pourquoi les r\u00e9sultats globaux et de sous-groupes ont-ils diff\u00e9r\u00e9 ? | NHD","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3714.jpg","datePublished":"2026-10-09T14:21:35+00:00","dateModified":"2026-10-11T08:32:59+00:00","description":"Apprenez \u00e0 lire un essai sur 148 personnes sans s\u00e9lectionner uniquement son r\u00e9sultat le plus favorable.","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3714.jpg","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/10\/nhd-comic-3714.jpg","width":1536,"height":1024,"caption":"Editorial comic illustration: LL-37 Wound Research. Conceptual cover, not experimental imagery."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ll37-venous-ulcer-trial-overall-versus-subgroup\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"LL-37 Wound Trial: Why Did the Overall and Subgroup Results Differ?"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mati\u00e8res premi\u00e8res peptidiques et synth\u00e8se sur mesure","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"\u00c9quipe technique NHD","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"L'\u00e9quipe technique NHD maintient la documentation du catalogue d'utilisation de la recherche et les r\u00e9sum\u00e9s des preuves. Les articles examin\u00e9s renvoient \u00e0 des articles \u00e9valu\u00e9s par des pairs, \u00e0 des registres d'essais et \u00e0 des dossiers r\u00e9glementaires, conservent les r\u00e9sultats nuls et les limites des \u00e9tudes, et distinguent les interventions publi\u00e9es des documents du catalogue. Le dessin assist\u00e9 par AI peut \u00eatre utilis\u00e9 pour la structure\u00a0; les liens vers les sources et les limites des preuves restent visibles. Ce travail ne constitue pas un examen ind\u00e9pendant par des pairs ni un avis m\u00e9dical.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/fr\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/3714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/comments?post=3714"}],"version-history":[{"count":3,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/3714\/revisions"}],"predecessor-version":[{"id":4202,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/posts\/3714\/revisions\/4202"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media\/3927"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/media?parent=3714"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/categories?post=3714"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/fr\/wp-json\/wp\/v2\/tags?post=3714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}